Piperazine derivatives and their use as leptin receptor modulators

Details for Australian Patent Application No. 2008333183 (hide)

Owner AstraZeneca AB (Publ)

Inventors Simpson, Iain; Horgan, Viet-Anh Anne (nee Nguyen); Higginbottom, Michael; Brown, Giles A.; Ouzman, Jacqueline; Boyd, Joseph W.

Agent Davies Collison Cave

Pub. Number AU-A-2008333183

PCT Pub. Number WO2009/071668

Priority 61/022,933 23.01.08 US; 0702697-4 05.12.07 SE

Filing date 5 December 2008

Wipo publication date 11 June 2009

International Classifications

C07D 295/205 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/071668 Priority application(s): WO2009/071668

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008333190-Method of forwarding messages over a network and system for implementing the method

2008333180-Apparatus and method for detecting DNA damage